Cargando…
Fcgbp – A Potential Viral Trap in RV144
Years of extensive research have yielded much knowledge in many aspects of HIV-1 infection, treatments, and education. However, without a vaccine, the number of people infected worldwide continues to grow. The partial success of the Thai RV144 vaccine trial provides hope that a method of protection...
Autor principal: | Schwartz, Jacquelyn L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166788/ https://www.ncbi.nlm.nih.gov/pubmed/25246998 http://dx.doi.org/10.2174/1874613601408010021 |
Ejemplares similares
-
Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
por: Gómez-Garre, Pilar, et al.
Publicado: (2022) -
Molecular epidemiology of the protective RV144 V2 loop epitope
por: Cardozo, T
Publicado: (2012) -
RV144 HIV-1 vaccination impacts post-infection antibody responses
por: Mdluli, Thembi, et al.
Publicado: (2020) -
FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022) -
Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer
por: Liu, Qiao, et al.
Publicado: (2022)